Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from China Life Insurance Co ( (HK:2628) ).
China Life Insurance Company Limited has released its solvency quarterly report summary for the first quarter of 2026, prepared under China’s updated Solvency Regulatory Rules II and related guidance issued by national regulators. The disclosure underscores the company’s adherence to evolving solvency and risk management standards, signaling ongoing regulatory compliance and providing stakeholders with insight into its capital adequacy under the current supervisory framework.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$33.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major Chinese life insurer operating across the People’s Republic of China, excluding Hong Kong, Macau and Taiwan. The company offers life, health, accident and other personal insurance products, along with reinsurance, fund management, personal insurance services, consulting, agency business and the sale of securities investment funds.
Average Trading Volume: 60,458,423
Technical Sentiment Signal: Buy
Current Market Cap: HK$1076.1B
See more insights into 2628 stock on TipRanks’ Stock Analysis page.